RESITRA: RED DE ESTUDIO DE LA INFECCION EN EL TRASPLANTE
Datos básicos
- NumeroConcesion:
- G03/075
- Año inicial:
- 2003
- Año final:
- 2015
Objetivos del proyecto
FINALIZADO
Documentos
- No hay documentos
Participantes
Financiadores
Resultados del Proyecto
A young patient with fever after heart transplantation
Ramos, A; (...); Bouza, E
Editorial Material. 2018
Boosted protease inhibitor monotherapy in HIV-infected patients: results of a study in a real life setting
Di Benedetto N; (...); Salavert M
Article. 2015
Bortezomib-based induction therapy followed by intravenous busulfan-melphalan as conditioning regimen for patients with newly diagnosed multiple myeloma
Blanes M; (...); de la Rubia J
Article. 10.3109/10428194.2014.922182. 2015
Cellulitis in adult patients: A large, multicenter, observational, prospective study of 606 episodes and analysis of the factors related to the response to treatment
Collazos, J; (...); Asensi, V
Article. 10.1371/journal.pone.0204036. 2018
Cerebral phaeohyphomycosis: Description of a case and review of the literature
Frasquet-Artés JS; (...); López-Hontangas JL
Review. 10.1016/j.riam.2012.12.008. 2014
Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study
Lopez-Medrano, F; (...); STCS
Article. 10.1111/ajt.13837. 2016
Current management of CMV infection in cancer patients (solid tumors). Epidemiology and therapeutic strategies.
Garcia-Bustos, Victor; (...); Blanes, Marino
Article. 10.37201/req/s03.16.2022. 2022
Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors
Asensi, V; (...); Pineda, JA
Article. 10.1371/journal.pone.0221598. 2019
Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients
Cordero, E; (...); Perez-Romero, P
Article. 10.3389/fimmu.2020.01917. 2020
Efficacy and safety of a booster dose of influenza vaccination in solid organ transplant recipients, TRANSGRIPE 1-2: study protocol for a multicenter, randomized, controlled clinical trial
Martinez-Atienza, J; (...); Cordero, E
Article. 10.1186/1745-6215-15-338. 2014
Enterococcus spp. and Streptococcus spp. bloodstream infections: epidemiology and therapeutic approach.
Blanes Hernández R, Blanes Juliá M
Article. 10.37201/req/s01.01.2023. 2023
Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of Donors of Solid Organs in relation to Infectious Diseases.
Len O; (...); Domínguez-Gil B
Article. 10.1016/j.eimc.2019.10.016. 2019
Factors associated with sepsis development in 606 Spanish adult patients with cellulitis
Collazos, J; (...); Asensi, V
Article. 10.1186/s12879-020-4915-1. 2020
Feohifomicosis cerebral: Descriptción de un caso y revisión de la literatura
Frasquet-Artés JS; (...); López-Hontangas JL.
Article. 2014
Haemophagocytic syndrome in a liver transplant patient during treatment with Telaprevir.
Rodríguez-Medina B; (...); Berenguer M
Article. 10.1016/S1665-2681(19)31305-5. 2013
Human Immunodeficiency Virus Infection Does Not Worsen Prognosis of Liver Transplantation for Hepatocellular Carcinoma
Aguro, F; (...); FIPSE Investigators
Article. 10.1002/hep.28321. 2016
Human immunodeficiency virus-infected liver transplant recipients with incidental hepatocellular carcinoma: A prospective multicenter nationwide cohort study
Aguero, F; (...); FIPSE Investigators
Article. 10.1002/lt.24741. 2017
Infective endocarditis due to Tropheryma whipplei: A current challenge
Dominguez-Massa, C; (...); Hornero-Sosa, F
Article. 10.1016/j.circv.2019.01.076. 2019
Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe
Perez-Romero, P; (...); Influenza Vaccine Solid Organ
Article. 10.1016/j.cmi.2015.07.014. 2015
Intravenous busulfan and melphalan as a conditioning regimen for autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: a matched comparison to a melphalan-only approach.
Blanes M; (...); de la Rubia J
Article. 10.1016/j.bbmt.2012.08.009. 2013
Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma
Blanes, M; (...); de la Rubia, J
Letter. 10.1007/s00277-019-03663-5. 2019
Intravenous Busulfan-Melphalan vs Melphalan as Preparative Regimen for Newly Diagnosed Multiple Myeloma: Long-Term Follow-Up of a Case-Control Study
Blanes, M; (...); de la Rubia, J
Meeting Abstract. 10.1016/j.clml.2019.09.473. 2019
Intravenous busulphan plus melphalan versus melphalan alone as conditioning regimen for newly diagnosed patients with multiple myeloma: Long-term follow-up of a matched case-controlled study
Blanes, M; (...); de la Rubia, J
Meeting Abstract. 2019
Is Visceral Leishmaniasis Different in Immunocompromised Patients Without Human Immunodeficiency Virus? A Comparative, Multicenter Retrospective Cohort Analysis
Ramos, JM; (...); Portilla, J
Article. 10.4269/ajtmh.16-0940. 2017
Lipoprotein (a) in young individuals as a marker of the presence of ischemic heart disease and the severity of coronary lesions
Zorio, E; (...); Estelles, A
Article. 2006
Membranous glomerulonephritis and cellular crescents induced by levamisole-adulterated cocaine abuse: a case report.
Roca-Argente L; (...); Hernández-Jaras J
Article. 10.3978/j.issn.2305-5839.2015.10.29. 2015
Mild profile improvement of immune biomarkers in HIV/HCV-coinfected patients who removed hepatitis C after HCV treatment: A prospective study
Garcia-Broncano, P; (...); GESIDA 3603b Study Grp
Article. 10.1016/j.jinf.2019.09.020. 2020
Mitral repair results in endocarditis
Dominguez-Massa, C; (...); Montero-Argudo, JA
Article. 10.1016/j.circv.2020.08.005. 2020
Multidrug resistant bacterial infections after liver transplantation: prevalence, impact and associated risk factors
Martin-Mateos, Rosa; (...); Albillos, Agustin
Meeting Abstract. 2022
Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors.
Martin-Mateos R; (...); Albillos A
Article. 10.1016/j.jhep.2024.02.023. 2024
Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation
Lopez-Medrano, F; (...); Swiss Transplant Cohort Study STCS
Article. 10.1016/j.cmi.2017.06.016. 2018
Mycobacterium genavense Infections in a Tertiary Hospital and Reviewed Cases in Non-HIV Patients.
Santos M; (...); Gobernado M
Article. 10.1155/2014/371370. 2014
Peritransplant Antiviral Treatment of Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients
Vinaixa, C; (...); Prieto, M
Letter. 10.1002/lt.25297. 2018
Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R-): experience from the RESITRA-REIPI cohort
Meije, Y; (...); Gavalda, J
Article. 10.1111/tid.12226. 2014
Primary Central Nervous System Posttransplant Lymphoproliferative Disease in a Bilateral Transfemoral Lower Extremity Transplantation Recipient
Cavadas, PC; (...); Mayordomo-Aranda, E
Article. 10.1111/ajt.13313. 2015
Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
Vigon, L; (...); Esteban, H
Article. 10.1038/s41598-019-48592-5. 2019
Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010-2015
Gonzalez, J; (...); Cohort Spanish HIV Res Network Co
Article. 10.1016/j.eimc.2019.02.007. 2019
Repeated CMV infection in a heart transplantation patient.
Melero-Ferrer J; (...); Salvador-Sanz A
Article. 10.1155/2012/305920. 2012
Risk Factors Associated With Early Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: Results From a Multinational Matched Case-Control Study
Lopez-Medrano, F; (...); Swiss Transplant Cohort Study STCS
Article. 10.1111/ajt.13735. 2016
Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study
Salto-Alejandre, S; (...); Cordero, E
Article. 10.1371/journal.pone.0250796. 2021
Role of autologous bone marrow transplant in multiple myeloma.
Article. 10.1097/CCO.0b013e328358f686. 2012
Safety of anidulafungin in solid organ transplant recipients.
Aguado JM; (...); Montejo M
Article. 10.1002/lt.23410. 2012
Selection criteria of solid organ donors in relation to infectious diseases: A Spanish consensus.
Len O; (...); Domínguez-Gil B
Review. 10.1016/j.trre.2020.100528. 2020
Sex differences in hospitalized adult patients with cellulitis: A prospective, multicenter study.
Collazos J; (...); Asensi V
Article. 10.1016/j.ijid.2021.01.044. 2021
Tuberculosis Prophylaxis With Levofloxacin in Liver Transplant Patients Is Associated With a High Incidence of Tenosynovitis: Safety Analysis of a Multicenter Randomized Trial
Torre-Cisneros, J; (...); Aguado, JM
Article. 10.1093/cid/civ156. 2015
Two Doses of Inactivated Influenza Vaccine Improve Immune Response in Solid Organ Transplant Recipients: Results of TRANSGRIPE 1-2, a Randomized Controlled Clinical Trial
Cordero, E; (...); TRANSGRIPE 1-2 Study Group
Article. 10.1093/cid/ciw855. 2017
VDR rs2228570 Polymorphism Is Related to Non-Progression to AIDS in Antiretroviral Therapy Naive HIV-Infected Patients
Jimenez-Sousa, MA; (...); LTNPs Cohort
Article. 10.3390/jcm8030311. 2019
Campos de Estudio
Cita
RESITRA: RED DE ESTUDIO DE LA INFECCION EN EL TRASPLANTE. (G03/075). INSTITUTO DE SALUD CARLOS III. 2003-2015.